Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer

Lessons learned from the us armed forces: Consensus and future directions

Itzhak Avital, Russell C. Langan, Thomas A. Summers, Scott R. Steele, Scott A. Waldman, Vadim Backman, Judy Yee, Aviram Nissan, Patrick Young, Craig Womeldorph, Paul Mancusco, Renee Mueller, Khristian Noto, Warren Grundfest, Anton J. Bilchik, Mladjan Protic, Martin Daumer, John Eberhardt, Yan Gao Man, Björn LDM Brücher & 1 others Alexander Stojadinovic

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States (U.S.), with estimates of 143,460 new cases and 51,690 deaths for the year 2012. Numerous organizations have published guidelines for CRC screening; however, these numerical estimates of incidence and disease-specific mortality have remained stable from years prior. Technological, genetic profiling, molecular and surgical advances in our modern era should allow us to improverisk stratification of patients with CRC and identify those who may benefit from preventive measures, early aggressive treatment, alternative treatment strategies, and/or frequent surveillance for the early detection of disease recurrence. To better negotiate future economic constraints and enhance patient outcomes, ultimately, we propose to apply the principals of personalized and precise cancer care to risk-stratify patients for CRC screening (Precision Risk Stratification- Based Screening, PRSBS). We believe that genetic, molecular, ethnic and socioeconomic disparities impact oncological outcomes in general, those related to CRC, in particular. This document highlights evidence-based screening recommendations and risk stratification methods in response to our CRC working group private-public consensus meeting held in March 2012. Our aim was to address how we could improve CRC risk stratification-based screening, and to provide a vision for the future to achieving superior survival rates for patients diagnosed with CRC.

Original languageEnglish (US)
Pages (from-to)172-192
Number of pages21
JournalJournal of Cancer
Volume4
Issue number3
DOIs
StatePublished - Aug 30 2013
Externally publishedYes

Fingerprint

Colorectal Neoplasms
Consensus
Guidelines
Early Detection of Cancer
Molecular Biology
Direction compound
Early Diagnosis
Neoplasms
Survival Rate
Economics
Organizations
Recurrence
Mortality
Incidence
Therapeutics

Keywords

  • Cancer screening
  • Colon
  • Colorectal cancer
  • Consensus
  • Evidence-based medicine
  • Rectal
  • Risk identification

ASJC Scopus subject areas

  • Oncology

Cite this

Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer : Lessons learned from the us armed forces: Consensus and future directions. / Avital, Itzhak; Langan, Russell C.; Summers, Thomas A.; Steele, Scott R.; Waldman, Scott A.; Backman, Vadim; Yee, Judy; Nissan, Aviram; Young, Patrick; Womeldorph, Craig; Mancusco, Paul; Mueller, Renee; Noto, Khristian; Grundfest, Warren; Bilchik, Anton J.; Protic, Mladjan; Daumer, Martin; Eberhardt, John; Man, Yan Gao; Brücher, Björn LDM; Stojadinovic, Alexander.

In: Journal of Cancer, Vol. 4, No. 3, 30.08.2013, p. 172-192.

Research output: Contribution to journalReview article

Avital, I, Langan, RC, Summers, TA, Steele, SR, Waldman, SA, Backman, V, Yee, J, Nissan, A, Young, P, Womeldorph, C, Mancusco, P, Mueller, R, Noto, K, Grundfest, W, Bilchik, AJ, Protic, M, Daumer, M, Eberhardt, J, Man, YG, Brücher, BLDM & Stojadinovic, A 2013, 'Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer: Lessons learned from the us armed forces: Consensus and future directions', Journal of Cancer, vol. 4, no. 3, pp. 172-192. https://doi.org/10.7150/jca.5834
Avital, Itzhak ; Langan, Russell C. ; Summers, Thomas A. ; Steele, Scott R. ; Waldman, Scott A. ; Backman, Vadim ; Yee, Judy ; Nissan, Aviram ; Young, Patrick ; Womeldorph, Craig ; Mancusco, Paul ; Mueller, Renee ; Noto, Khristian ; Grundfest, Warren ; Bilchik, Anton J. ; Protic, Mladjan ; Daumer, Martin ; Eberhardt, John ; Man, Yan Gao ; Brücher, Björn LDM ; Stojadinovic, Alexander. / Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer : Lessons learned from the us armed forces: Consensus and future directions. In: Journal of Cancer. 2013 ; Vol. 4, No. 3. pp. 172-192.
@article{71b48614d1a644b9a54f8d64eb342e5b,
title = "Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer: Lessons learned from the us armed forces: Consensus and future directions",
abstract = "Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States (U.S.), with estimates of 143,460 new cases and 51,690 deaths for the year 2012. Numerous organizations have published guidelines for CRC screening; however, these numerical estimates of incidence and disease-specific mortality have remained stable from years prior. Technological, genetic profiling, molecular and surgical advances in our modern era should allow us to improverisk stratification of patients with CRC and identify those who may benefit from preventive measures, early aggressive treatment, alternative treatment strategies, and/or frequent surveillance for the early detection of disease recurrence. To better negotiate future economic constraints and enhance patient outcomes, ultimately, we propose to apply the principals of personalized and precise cancer care to risk-stratify patients for CRC screening (Precision Risk Stratification- Based Screening, PRSBS). We believe that genetic, molecular, ethnic and socioeconomic disparities impact oncological outcomes in general, those related to CRC, in particular. This document highlights evidence-based screening recommendations and risk stratification methods in response to our CRC working group private-public consensus meeting held in March 2012. Our aim was to address how we could improve CRC risk stratification-based screening, and to provide a vision for the future to achieving superior survival rates for patients diagnosed with CRC.",
keywords = "Cancer screening, Colon, Colorectal cancer, Consensus, Evidence-based medicine, Rectal, Risk identification",
author = "Itzhak Avital and Langan, {Russell C.} and Summers, {Thomas A.} and Steele, {Scott R.} and Waldman, {Scott A.} and Vadim Backman and Judy Yee and Aviram Nissan and Patrick Young and Craig Womeldorph and Paul Mancusco and Renee Mueller and Khristian Noto and Warren Grundfest and Bilchik, {Anton J.} and Mladjan Protic and Martin Daumer and John Eberhardt and Man, {Yan Gao} and Br{\"u}cher, {Bj{\"o}rn LDM} and Alexander Stojadinovic",
year = "2013",
month = "8",
day = "30",
doi = "10.7150/jca.5834",
language = "English (US)",
volume = "4",
pages = "172--192",
journal = "Journal of Cancer",
issn = "1837-9664",
publisher = "Ivyspring International Publisher",
number = "3",

}

TY - JOUR

T1 - Evidence-based guidelines for precision risk stratification- based screening (PRSBS) for colorectal cancer

T2 - Lessons learned from the us armed forces: Consensus and future directions

AU - Avital, Itzhak

AU - Langan, Russell C.

AU - Summers, Thomas A.

AU - Steele, Scott R.

AU - Waldman, Scott A.

AU - Backman, Vadim

AU - Yee, Judy

AU - Nissan, Aviram

AU - Young, Patrick

AU - Womeldorph, Craig

AU - Mancusco, Paul

AU - Mueller, Renee

AU - Noto, Khristian

AU - Grundfest, Warren

AU - Bilchik, Anton J.

AU - Protic, Mladjan

AU - Daumer, Martin

AU - Eberhardt, John

AU - Man, Yan Gao

AU - Brücher, Björn LDM

AU - Stojadinovic, Alexander

PY - 2013/8/30

Y1 - 2013/8/30

N2 - Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States (U.S.), with estimates of 143,460 new cases and 51,690 deaths for the year 2012. Numerous organizations have published guidelines for CRC screening; however, these numerical estimates of incidence and disease-specific mortality have remained stable from years prior. Technological, genetic profiling, molecular and surgical advances in our modern era should allow us to improverisk stratification of patients with CRC and identify those who may benefit from preventive measures, early aggressive treatment, alternative treatment strategies, and/or frequent surveillance for the early detection of disease recurrence. To better negotiate future economic constraints and enhance patient outcomes, ultimately, we propose to apply the principals of personalized and precise cancer care to risk-stratify patients for CRC screening (Precision Risk Stratification- Based Screening, PRSBS). We believe that genetic, molecular, ethnic and socioeconomic disparities impact oncological outcomes in general, those related to CRC, in particular. This document highlights evidence-based screening recommendations and risk stratification methods in response to our CRC working group private-public consensus meeting held in March 2012. Our aim was to address how we could improve CRC risk stratification-based screening, and to provide a vision for the future to achieving superior survival rates for patients diagnosed with CRC.

AB - Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States (U.S.), with estimates of 143,460 new cases and 51,690 deaths for the year 2012. Numerous organizations have published guidelines for CRC screening; however, these numerical estimates of incidence and disease-specific mortality have remained stable from years prior. Technological, genetic profiling, molecular and surgical advances in our modern era should allow us to improverisk stratification of patients with CRC and identify those who may benefit from preventive measures, early aggressive treatment, alternative treatment strategies, and/or frequent surveillance for the early detection of disease recurrence. To better negotiate future economic constraints and enhance patient outcomes, ultimately, we propose to apply the principals of personalized and precise cancer care to risk-stratify patients for CRC screening (Precision Risk Stratification- Based Screening, PRSBS). We believe that genetic, molecular, ethnic and socioeconomic disparities impact oncological outcomes in general, those related to CRC, in particular. This document highlights evidence-based screening recommendations and risk stratification methods in response to our CRC working group private-public consensus meeting held in March 2012. Our aim was to address how we could improve CRC risk stratification-based screening, and to provide a vision for the future to achieving superior survival rates for patients diagnosed with CRC.

KW - Cancer screening

KW - Colon

KW - Colorectal cancer

KW - Consensus

KW - Evidence-based medicine

KW - Rectal

KW - Risk identification

UR - http://www.scopus.com/inward/record.url?scp=84883027640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883027640&partnerID=8YFLogxK

U2 - 10.7150/jca.5834

DO - 10.7150/jca.5834

M3 - Review article

VL - 4

SP - 172

EP - 192

JO - Journal of Cancer

JF - Journal of Cancer

SN - 1837-9664

IS - 3

ER -